{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:45:38Z","timestamp":1781372738175,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":4486,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.fertnstert.2009.02.086","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T05:06:22Z","timestamp":1238648782000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased secretion of amylin in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"94","author":[{"given":"Summer","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moralez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manubai","family":"Nagamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.02.086_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1100\/tsw.2006.263","article-title":"Amylin in the periphery II: an updated mini-review","volume":"6","author":"Wookey","year":"2006","journal-title":"Scientific World J"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib3","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","article-title":"Amylin found in amyloid deposits in human type 2 diabetes may be a hormone that regulates glycogen metabolism in skeletal muscle","volume":"85","author":"Cooper","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/oby.2002.147","article-title":"Amylin, food intake and obesity","volume":"10","author":"Reda","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0165-6147(93)90081-T","article-title":"Structure and biology of amylin","volume":"14","author":"Rink","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"\u03b2-cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","article-title":"Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women","volume":"84","author":"Carmina","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib10","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib11","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib13","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib14","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/oby.2007.239","article-title":"Amylin and its relation to insulin and lipids in obese children before and after weight loss","volume":"15","author":"Reinehr","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib15","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diab.40.12.1615","article-title":"Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes","volume":"40","author":"Ludvik","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/014572179902500310","article-title":"Clinical implications of amylin and amylin deficiency","volume":"25","author":"Kruger","year":"1999","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0006-291X(05)81133-7","article-title":"Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin resistant diabetic rats","volume":"180","author":"Gedulin","year":"1991","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib18","first-page":"E903","article-title":"Distribution and kinetics of amylin in humans","volume":"274","author":"Clodi","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib20","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib22","doi-asserted-by":"crossref","first-page":"E1023","DOI":"10.1152\/ajpendo.00532.2003","article-title":"Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion","volume":"286","author":"Leclerc","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib23","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2337\/diabetes.54.7.2235","article-title":"Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide","volume":"54","author":"Hull","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib24","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib25","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db07-0197","article-title":"High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes","volume":"56","author":"Huang","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1559-4564.2006.05675.x","article-title":"Polycystic ovarian syndrome","volume":"1","author":"Khan","year":"2006","journal-title":"J\u00a0Cardiometab Syndr"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1440-1681.2000.03255.x","article-title":"Islet amyloid polypeptide (amylin) modulates chylomicron metabolism in rats","volume":"27","author":"Smith","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib29","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/00004872-200018110-00012","article-title":"Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk","volume":"18","author":"Kailasam","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000057400","article-title":"Interaction of the renal amylin and renin-angiotensin systems in animal models of diabetes and hypertension","volume":"24","author":"Wookey","year":"1998","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib31","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1210\/jc.2006-0399","article-title":"Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome","volume":"91","author":"Cascella","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0026-895X(25)09678-6","article-title":"Cloning and characterization of an abundant subtype of the human calcitonin receptor","volume":"46","author":"Kuestner","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.fertnstert.2009.02.086_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(00)00585-9","article-title":"Expression of adrenomedullin in the human corpus luteum","volume":"74","author":"Abe","year":"2000","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209005135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209005135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:42:01Z","timestamp":1773682921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209005135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0015028209005135"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.086","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased secretion of amylin in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}